PRTN3 and anti-neutrophil cytoplasmic antibody-associated vasculitis: In the case of ANCA-associated vasculitis with its formation of PR3 antibodies by autoreactive B cells, a CD20-depleting therapy with RTX has consequently been established as a reliable option for induction and maintenance therapy alike.